Approximately 20% of cancer clinical trials will never be completed, because they fail to enroll enough participants to be able to answer the research question. Read this white paper to learn the impact that participant payments may play on clinical trial recruitment.
It is important to understand patient perspectives and to anticipate how subjects in research studies may b...
Most Recent Flipbooks
In a recent webinar, Steven Beales, Senior VP, Scientific and Regulatory at WCG, facilitated a conversation with FDA leaders, discussing overreporting SUSARs and the impact on patient safety.
16 industry experts share shifts and trends that will inform clinical research in 2020 and beyond.